Table 1.
Proteins with cryptic sides studied
Apoa | Holoa | Ligb | Name | Nc | Figure | Site |
---|---|---|---|---|---|---|
2CM2_A | 2H4K_A | 509 | PTP1B | 19 | 1 | High affinity pTyr binding site |
1 PKL_B | 3HQP_P | ATP | Pyruvate kinase enzyme | 10 | 3A | ATP+Oxalate binding site |
1RTC_A | 1BR6_A | PT1 | Ricin | 23 | 3B | Pteroic acid binding at the active site |
1RHB_A | 2W5K_B | NDP | Ribonuclease A. | 83 | 3C | NADPH binding at the active site |
3CJ0_A | 2BRL_A | POO | HCV polymerase NS5B | 249 | 3D | Between fingers and thumb domains |
2F6V_A | 1T49_A | 892 | PTP1B | 108 | 3E | Allosteric site under the C-terminal helix |
1ZAH_B | 2OT1_D | N3P | Fructose aldolase | 36 | 3F | Competitive inhibitor binding site |
1 G24_D | 1GZF_C | NIR | Rho ADP-Ribosyl. Enz. | 15 | S1 | Structure also contain NAD and ADP |
1 W50_A | 3IXJ_C | 586 | BACE-1 protease | 19 | 4 | Active site, too open in apo structure |
1BSQ_A | 1 GX8_A | RTL | Bovine Beta-lactoglobulin | 34 | 5A | Retinol binding in the central cavity |
1HAG_E | 1GHY_H | 121 | Thrombin | 52 | 5B | Pocket is too open with flexible loops |
3F74_C | 3BQM_C | BQM | Alpha-L (Integrin) domain | 25 | 5C | Active site with disordered C terminus |
1MY0_B | 1N0T_D | AT1 | Glutamate receptor 2 | 26 | 5D | Stabilizes the open form of the receptor |
1XCG_B | 10W3_B | GDP | Transforming protein | 12 | S2 | GDP interacts only with RhoA |
1 JWP_A | 1 PZ0_A | CBT | TEM β-lactamase | 21 | 6 | Allosteric site between two helixes |
2BLS_B | 3GQZ_A | GF7 | AMPc beta-lactamase | 35 | 8A | Weak peripheral allosteric site |
2BU8_A | 2BU2_A | TF1 | Pyruvate dehyd. kinase | 11 | 8B | Allosteric inhibitor site |
3CJ0_A | 3FQK_B | 79Z | HCV polymerase NS5B | 143 | 8C | Binding near the active site. |
2BRK_A | 2GIR_B | NN3 | HCV polymerase NS5B | 186 | S3A | Non-nucleotide inhibitor (thumb) site |
1FXX_A | 3HL8_A | BBP | Exodeoxyribonuclease I | 14 | 8D | BBP prevents Exol/SSB interactions |
1OK8_A | 10KE_B | BOG | Dengue 2 virus envelope | 15 | 8E | Site is between two domains |
2AKA_A | 1 YV3_A | BIT | Myosin II | 30 | 8F | Narrow planar ligand binding site |
3MN9_A | 3EKS_A | CY9 | Monomer. actin with toxin | 36 | S3B | Binding to the barbed end of filaments |
1 NUW_A | 1 EYJ_B | AMP | Fruct. 1,6- bisphosphatase | 25 | S3C | AMP binding site |
3PUW_E | 1FQC_A | GLO | Maltodextrin/maltose BP | 19 | S3D | Interdomain binding |
3KQA_B | 3LTH_A | UD1 | MurA dead-end complex | 13 | S3E | Interdomain binding |
3GXD_B | 2WCG_A | MT5 | Acid-beta-glucosidase | 26 | S3F | Active site |
1BNC_B | 2V5A_A | LZL | Biotin carboxylase | 18 | S4A | ATP competitive inhibitor site |
1MY1_C | 1FTL_A | DNQ | Glutamate receptor 2. | 26 | S4B | Interdomain binding |
2AX9_A | 2PIQ_A | RB1 | Androgen receptor | 23 | S4C | Allosteric inhibitor binds on surface |
2ZB1_A | 2NPQ_A | BOG | P38 MAP kinase | 144 | S4D | Helix 253–261 moves outward |
2AIR_H | 1ZA1_D | CTP | Aspartate transcarbamylase |
60 | S5 | Binds CTP at the flexible N-terminal |
PDB ID of the apo and holo structures in the CryptoSite database.
Name of the ligand binding at the cryptic site.
Number of structures considered.